Search research articles
Contact Us
Filters
Showing results (281-290 of 359) with videos related to
Page
of 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2021
Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
Pengju Nie, Teja Kalidindi, Veronica L Nagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2026
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
Paul C Klauser, Gina Dehlavi, Michele De Franco, et al.
Organic & Biomolecular Chemistry
|
July 4, 2019
Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO
N V S Dinesh K Bhupathiraju, Ali Younes, Minhua Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer model
Edwin C Pratt, David Bauer, Lukas M Carter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models
Joseph A O'Donoghue, Pat Zanzonico, Andrei Pugachev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer
Joshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Nuclear Medicine and Biology
|
September 23, 2003
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals
Carla J Mathias, Michael R Lewis, David E Reichert, et al.
Cancer Research
|
October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Daniel E Spratt, Michael J Evans, Brian J Davis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
The Journal of Urology
|
October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy
Joseph R Osborne, David A Green, Daniel E Spratt, et al.
Page
of 36
Search research articles
Search
Showing results (281-290 of 359) with videos related to
Sort By:
Page
of 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2021
Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
Pengju Nie, Teja Kalidindi, Veronica L Nagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2026
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
Paul C Klauser, Gina Dehlavi, Michele De Franco, et al.
Organic & Biomolecular Chemistry
|
July 4, 2019
Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO
N V S Dinesh K Bhupathiraju, Ali Younes, Minhua Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer model
Edwin C Pratt, David Bauer, Lukas M Carter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models
Joseph A O'Donoghue, Pat Zanzonico, Andrei Pugachev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer
Joshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Nuclear Medicine and Biology
|
September 23, 2003
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals
Carla J Mathias, Michael R Lewis, David E Reichert, et al.
Cancer Research
|
October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Daniel E Spratt, Michael J Evans, Brian J Davis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
The Journal of Urology
|
October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy
Joseph R Osborne, David A Green, Daniel E Spratt, et al.
Page
of 36